Stocks and Investing
Stocks and Investing
Tue, March 17, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, March 16, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mani Foroohar Initiated (ADVM) at Buy and Held Target at $170 on, Mar 16th, 2020
Mani Foroohar of SVB Leerink, Initiated "Adverum Biotechnologies, Inc." (ADVM) at Buy and Held Target at $170 on, Mar 16th, 2020.
Mani has made no other calls on ADVM in the last 4 months.
There are 3 other peers that have a rating on ADVM. Out of the 3 peers that are also analyzing ADVM, 0 agree with Mani's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Mani
- Alethia Young of "Cantor Fitzgerald" Upgraded from Hold to Buy and Increased Target to $210 on, Monday, February 10th, 2020
- Gbola Amusa of "Chardan Capital" Upgraded from Hold to Strong Buy and Increased Target to $200 on, Monday, February 10th, 2020
- Tyler Van Buren of "Piper Sandler" Reiterated at Buy with Increased Target to $200 on, Monday, January 13th, 2020